Loading…
An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates
The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially...
Saved in:
Published in: | Angewandte Chemie 2021-02, Vol.133 (6), p.3045-3052 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 3052 |
container_issue | 6 |
container_start_page | 3045 |
container_title | Angewandte Chemie |
container_volume | 133 |
creator | Merkul, Eugen Muns, Joey A. Sijbrandi, Niels J. Houthoff, Hendrik‐Jan Nijmeijer, Bart Rheenen, Gerro Reedijk, Jan Dongen, Guus A. M. S. |
description | The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially |
doi_str_mv | 10.1002/ange.202011593 |
format | article |
fullrecord | <record><control><sourceid>proquest_wiley</sourceid><recordid>TN_cdi_proquest_journals_2484199650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2484199650</sourcerecordid><originalsourceid>FETCH-LOGICAL-p783-50bc152c43af7ff1e10bd1d2123d92fa3ff28f4d4e1a48de840b26f8d65accae3</originalsourceid><addsrcrecordid>eNo9kL9OwzAQxi0EEqWwMltiTrEd598YlVIihcLQ3XJiO3Vp7ZA4hWy8AzMvx5OQUuh0Ot13v_vuA-AaowlGiNxyU8kJQQRhHCT-CRjhgGDPj4LoFIwQotSLCU3OwUXbrhFCIYmSEfhKDZwppUstjYNTa9ZdxZ22BqZ13VherqCyzTDo6o02FbxruqqFzsLFoNpJmBqnCyu0bOFOc-hWEj67LIO5Ni-ygfn773q2HVg7KeAjN53ipesaXuiNdj206p_Rf3987vFHF7K9BGeKb1p59VfHYHk_W04fvPxpnk3T3Kuj2PcCVJTDryX1uYqUwhKjQmBBMPFFQhT3lSKxooJKzGksZExRQUIVizDgZcmlPwY3B-zg8rWTrWNr2zVmuMgIjSlOkjBAgyo5qN70RvasbvSWNz3DiO3jZ_v42TF-li7ms2Pn_wB2kX-x</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2484199650</pqid></control><display><type>article</type><title>An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates</title><source>Wiley</source><creator>Merkul, Eugen ; Muns, Joey A. ; Sijbrandi, Niels J. ; Houthoff, Hendrik‐Jan ; Nijmeijer, Bart ; Rheenen, Gerro ; Reedijk, Jan ; Dongen, Guus A. M. S.</creator><creatorcontrib>Merkul, Eugen ; Muns, Joey A. ; Sijbrandi, Niels J. ; Houthoff, Hendrik‐Jan ; Nijmeijer, Bart ; Rheenen, Gerro ; Reedijk, Jan ; Dongen, Guus A. M. S.</creatorcontrib><description>The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially <15 % to ca. 75–90 % conjugation efficiency is described, resulting from a systematic screening of all relevant reaction parameters. NaI, a strikingly simple inorganic salt additive, greatly improves the conjugation efficiency as well as the conjugation selectivity simply by exchanging the leaving chloride ligand on Cl‐Lx‐drug complexes (which are direct precursors for Lx‐ADCs) for iodide, thus generating I‐Lx‐drug complexes as more reactive species. Using this iodide effect, we developed a general and highly practical conjugation procedure that is scalable: our lead Lx‐ADC was produced on a 5 g scale with an outstanding conjugation efficiency of 89 %.
PtII complexes containing a payload, a bidentate ligand, and a halido leaving ligand (Cl−, Br− or I−) can be conjugated to native monoclonal antibodies in a very efficient way by using iodide salts, such as NaI, as simple inorganic additives to the aqueous conjugation mixtures. This method works reliably for various mAbs, consistently giving conjugation efficiencies in the range of 75–90 %.</description><identifier>ISSN: 0044-8249</identifier><identifier>EISSN: 1521-3757</identifier><identifier>DOI: 10.1002/ange.202011593</identifier><language>eng</language><publisher>Weinheim: Wiley Subscription Services, Inc</publisher><subject>Antibodies ; antibody–drug conjugates ; Chemistry ; Conjugates ; Conjugation ; Efficiency ; In vivo methods and tests ; Inorganic salts ; Iodides ; linkers ; Manufacturability ; platinum ; Selectivity</subject><ispartof>Angewandte Chemie, 2021-02, Vol.133 (6), p.3045-3052</ispartof><rights>2020 Wiley‐VCH GmbH</rights><rights>2020. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-2936-433X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Merkul, Eugen</creatorcontrib><creatorcontrib>Muns, Joey A.</creatorcontrib><creatorcontrib>Sijbrandi, Niels J.</creatorcontrib><creatorcontrib>Houthoff, Hendrik‐Jan</creatorcontrib><creatorcontrib>Nijmeijer, Bart</creatorcontrib><creatorcontrib>Rheenen, Gerro</creatorcontrib><creatorcontrib>Reedijk, Jan</creatorcontrib><creatorcontrib>Dongen, Guus A. M. S.</creatorcontrib><title>An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates</title><title>Angewandte Chemie</title><description>The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially <15 % to ca. 75–90 % conjugation efficiency is described, resulting from a systematic screening of all relevant reaction parameters. NaI, a strikingly simple inorganic salt additive, greatly improves the conjugation efficiency as well as the conjugation selectivity simply by exchanging the leaving chloride ligand on Cl‐Lx‐drug complexes (which are direct precursors for Lx‐ADCs) for iodide, thus generating I‐Lx‐drug complexes as more reactive species. Using this iodide effect, we developed a general and highly practical conjugation procedure that is scalable: our lead Lx‐ADC was produced on a 5 g scale with an outstanding conjugation efficiency of 89 %.
PtII complexes containing a payload, a bidentate ligand, and a halido leaving ligand (Cl−, Br− or I−) can be conjugated to native monoclonal antibodies in a very efficient way by using iodide salts, such as NaI, as simple inorganic additives to the aqueous conjugation mixtures. This method works reliably for various mAbs, consistently giving conjugation efficiencies in the range of 75–90 %.</description><subject>Antibodies</subject><subject>antibody–drug conjugates</subject><subject>Chemistry</subject><subject>Conjugates</subject><subject>Conjugation</subject><subject>Efficiency</subject><subject>In vivo methods and tests</subject><subject>Inorganic salts</subject><subject>Iodides</subject><subject>linkers</subject><subject>Manufacturability</subject><subject>platinum</subject><subject>Selectivity</subject><issn>0044-8249</issn><issn>1521-3757</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo9kL9OwzAQxi0EEqWwMltiTrEd598YlVIihcLQ3XJiO3Vp7ZA4hWy8AzMvx5OQUuh0Ot13v_vuA-AaowlGiNxyU8kJQQRhHCT-CRjhgGDPj4LoFIwQotSLCU3OwUXbrhFCIYmSEfhKDZwppUstjYNTa9ZdxZ22BqZ13VherqCyzTDo6o02FbxruqqFzsLFoNpJmBqnCyu0bOFOc-hWEj67LIO5Ni-ygfn773q2HVg7KeAjN53ipesaXuiNdj206p_Rf3987vFHF7K9BGeKb1p59VfHYHk_W04fvPxpnk3T3Kuj2PcCVJTDryX1uYqUwhKjQmBBMPFFQhT3lSKxooJKzGksZExRQUIVizDgZcmlPwY3B-zg8rWTrWNr2zVmuMgIjSlOkjBAgyo5qN70RvasbvSWNz3DiO3jZ_v42TF-li7ms2Pn_wB2kX-x</recordid><startdate>20210208</startdate><enddate>20210208</enddate><creator>Merkul, Eugen</creator><creator>Muns, Joey A.</creator><creator>Sijbrandi, Niels J.</creator><creator>Houthoff, Hendrik‐Jan</creator><creator>Nijmeijer, Bart</creator><creator>Rheenen, Gerro</creator><creator>Reedijk, Jan</creator><creator>Dongen, Guus A. M. S.</creator><general>Wiley Subscription Services, Inc</general><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><orcidid>https://orcid.org/0000-0002-2936-433X</orcidid></search><sort><creationdate>20210208</creationdate><title>An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates</title><author>Merkul, Eugen ; Muns, Joey A. ; Sijbrandi, Niels J. ; Houthoff, Hendrik‐Jan ; Nijmeijer, Bart ; Rheenen, Gerro ; Reedijk, Jan ; Dongen, Guus A. M. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p783-50bc152c43af7ff1e10bd1d2123d92fa3ff28f4d4e1a48de840b26f8d65accae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies</topic><topic>antibody–drug conjugates</topic><topic>Chemistry</topic><topic>Conjugates</topic><topic>Conjugation</topic><topic>Efficiency</topic><topic>In vivo methods and tests</topic><topic>Inorganic salts</topic><topic>Iodides</topic><topic>linkers</topic><topic>Manufacturability</topic><topic>platinum</topic><topic>Selectivity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Merkul, Eugen</creatorcontrib><creatorcontrib>Muns, Joey A.</creatorcontrib><creatorcontrib>Sijbrandi, Niels J.</creatorcontrib><creatorcontrib>Houthoff, Hendrik‐Jan</creatorcontrib><creatorcontrib>Nijmeijer, Bart</creatorcontrib><creatorcontrib>Rheenen, Gerro</creatorcontrib><creatorcontrib>Reedijk, Jan</creatorcontrib><creatorcontrib>Dongen, Guus A. M. S.</creatorcontrib><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Angewandte Chemie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Merkul, Eugen</au><au>Muns, Joey A.</au><au>Sijbrandi, Niels J.</au><au>Houthoff, Hendrik‐Jan</au><au>Nijmeijer, Bart</au><au>Rheenen, Gerro</au><au>Reedijk, Jan</au><au>Dongen, Guus A. M. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates</atitle><jtitle>Angewandte Chemie</jtitle><date>2021-02-08</date><risdate>2021</risdate><volume>133</volume><issue>6</issue><spage>3045</spage><epage>3052</epage><pages>3045-3052</pages><issn>0044-8249</issn><eissn>1521-3757</eissn><abstract>The PtII linker [ethylenediamineplatinum(II)]2+, coined Lx, has emerged as a novel non‐conventional approach to antibody–drug conjugates (ADCs) and has shown its potential in preclinical in vitro and in vivo benchmark studies. A crucial improvement of the Lx conjugation reaction from initially <15 % to ca. 75–90 % conjugation efficiency is described, resulting from a systematic screening of all relevant reaction parameters. NaI, a strikingly simple inorganic salt additive, greatly improves the conjugation efficiency as well as the conjugation selectivity simply by exchanging the leaving chloride ligand on Cl‐Lx‐drug complexes (which are direct precursors for Lx‐ADCs) for iodide, thus generating I‐Lx‐drug complexes as more reactive species. Using this iodide effect, we developed a general and highly practical conjugation procedure that is scalable: our lead Lx‐ADC was produced on a 5 g scale with an outstanding conjugation efficiency of 89 %.
PtII complexes containing a payload, a bidentate ligand, and a halido leaving ligand (Cl−, Br− or I−) can be conjugated to native monoclonal antibodies in a very efficient way by using iodide salts, such as NaI, as simple inorganic additives to the aqueous conjugation mixtures. This method works reliably for various mAbs, consistently giving conjugation efficiencies in the range of 75–90 %.</abstract><cop>Weinheim</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/ange.202011593</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-2936-433X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0044-8249 |
ispartof | Angewandte Chemie, 2021-02, Vol.133 (6), p.3045-3052 |
issn | 0044-8249 1521-3757 |
language | eng |
recordid | cdi_proquest_journals_2484199650 |
source | Wiley |
subjects | Antibodies antibody–drug conjugates Chemistry Conjugates Conjugation Efficiency In vivo methods and tests Inorganic salts Iodides linkers Manufacturability platinum Selectivity |
title | An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A43%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Efficient%20Conjugation%20Approach%20for%20Coupling%20Drugs%20to%20Native%20Antibodies%20via%20the%20PtII%20Linker%20Lx%20for%20Improved%20Manufacturability%20of%20Antibody%E2%80%93Drug%20Conjugates&rft.jtitle=Angewandte%20Chemie&rft.au=Merkul,%20Eugen&rft.date=2021-02-08&rft.volume=133&rft.issue=6&rft.spage=3045&rft.epage=3052&rft.pages=3045-3052&rft.issn=0044-8249&rft.eissn=1521-3757&rft_id=info:doi/10.1002/ange.202011593&rft_dat=%3Cproquest_wiley%3E2484199650%3C/proquest_wiley%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p783-50bc152c43af7ff1e10bd1d2123d92fa3ff28f4d4e1a48de840b26f8d65accae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2484199650&rft_id=info:pmid/&rfr_iscdi=true |